Dopaminergic neurons of the substantia nigra are susceptible to toxin-based insults. Intrastriatal injection of 6-hydroxydopamine results in selective toxicity to these neurons. A mechanistic role for reactive oxygen species is supported by observations that antioxidants confer protection from 6-hydroxydopamine. While cell culture studies have suggested extracellular or non-mitochondrial mechanisms in 6-hydroxydopamine toxicity, the compartmentalization of oxidative injury mechanisms is incompletely defined in vivo. Transgenic mice overexpressing mitochondrial manganese superoxide dismutase or extracellular superoxide dismutase received unilateral intrastriatal injections of 6-hydroxydopamine. Mice that overexpress manganese superoxide dismutase showed significantly smaller striatal lesions than littermate controls. There were no differences in nonspecific striatal injury associated with contralateral vehicle injection. Manganese superoxide dismutase overexpression also protected against loss of neuronal cell bodies in the substantia nigra. In contrast, mice overexpressing extracellular superoxide dismutase showed no protection from 6-hydroxydopamine toxicity in either brain region. Protection of the nigrostriatal system by overexpression of manganese superoxide dismutase supports a role for mitochondriallyderived superoxide in 6-hydroxydopamine toxicity. Mitochondrial oxidative stress appears to be a common mechanism among diverse models of Parkinson's disease, whether involving toxins, mutated genes, or cybrid cells containing patient mitochondria. Antioxidant therapies that target this subcellular compartment may prove promising.
INTRODUCTION
Reactive oxygen species (ROS) 1 have been hypothesized to play a mechanistic role in central nervous system diseases including stroke, seizures, and neurodegeneration. However, administration of a given antioxidant may show beneficial, indifferent, or harmful effects in different model systems. For example, superoxide dismutase (SOD) isoforms can exacerbate brain injuries mediated by nitric oxide or hydrogen peroxide (1, 2) , while protecting against other brain injuries (3) (4) (5) . Extracellular inhibition of oxidative reactions may promote toxicity inside of cultured cells by allowing higher levels of unaltered toxin to enter the cell (6) . Likewise, individual metal chelators may stimulate, inhibit or show no effect on catecholamine autoxidation, while the combination of SOD and chelators is generally inhibitory (7) . Given the growing recognition of ROS as mediators of cellular communication (8, 9) , understanding the compartments or sites of ROS generation that contribute to injury will facilitate appropriate targeting of antioxidant therapies.
Parkinson's disease is a common neurodegenerative disease characterized by disabling movement abnormalities. While it is known that injury to substantia nigra pars compacta (SNc) neurons of the nigrostriatal projection leads to parkinsonian symptoms, the mechanisms contributing to dysfunction and death of these dopaminergic neurons are incompletely understood (10) . The nigrostriatal system is particularly susceptible to toxin-based insults (11, 12) . While selective uptake of toxic metabolites may account in part for this sensitivity (13, 14) , recent discoveries that systemic mitochondrial complex I inhibition also causes selective nigrostriatal toxicity implicates intrinsic vulnerability of this system to toxic insults (15) . As the mechanisms of parkinsonian neurodegeneration are likely to involve multifactorial interactions (16, 17) , a better understanding of common pathways of SNc injury and death mechanisms will facilitate development of new treatments.
The dopamine analog 6-hydroxydopamine (6-OHDA) is a neurotoxin that injures catecholaminergic neurons of the central and peripheral nervous systems. Intrastriatal injection of 6-OHDA induces selective damage to dopaminergic terminals in the striatum followed by progressive degeneration of the dopaminergic cell bodies in the ipsilateral SNc in rats (18) (19) (20) and mice (21) . Loss of midbrain TH/DAT expressing neurons is highly concordant with loss of SNc neurons as assessed by phenotype-independent measures (Nissl stain, fluorogold labeling or nuclear counts), indicating that reversible suppression of TH expression is not a major factor in the rat intrastriatal injection model (18) (19) (20) 22) .
A mechanistic role for reactive oxygen species is supported by observations that antioxidants confer protection from 6-OHDA toxicity in vivo (23) (24) (25) (26) (27) (28) (29) and in vitro (30) (31) (32) (33) (34) .
T r a d i t i o n a l l y , 6 -O H D A -i n d u c e d neurotoxicity has been attributed to direct production of ROS during oxidation of this compound at neutral pH (35) . Certainly, the abilities of glutathione, N-acetylcysteine or metal chelators to protect against 6-OHDA toxicity support involvement of ROS. However, it is not always clear whether the antioxidant compound acts directly on 6-OHDA by affecting autooxidation rates (36, 37) , or if 6-OHDA initiates alternative cellular mechanisms of ROS generation that can be modulated by antioxidant treatment. The mitochondrion is a major source of intracellular ROS. While 6-OHDA can affect activity of isolated mitochondrial complexes (38) , cell culture experiments show conflicting results concerning the potential role of mitochondria in 6-OHDA injury (39) (40) (41) . Moreover, it has been postulated that 6-OHDA induces neuron death primarily through activation of endoplasmic reticulum stress responses (42, 43) . 6-OHDA injury can also be initiated by extracellular mechanisms (36) , even in systems showing high rates of dopamine transporter activities (40, 44) . One such mechanism may involve modulation of amino acid and catecholamine uptake without need for 6-OHDA internalization (45) .
Compartmentalization of oxidant stresses is often difficult to study as many antioxidant compounds cross between subcellular compartments, and ROS detection systems can be limited by the propensity for promoting generation of the free radical to be measured (46). There are three major human SOD family members, which differ in their subcellular localization: the cytosolic and nuclear copper/zinc SOD (CuZnSOD), the mitochondrial manganese SOD (MnSOD), and a multimeric, extracellular copper/zinc isoform (EC-SOD) (47) . Transgenic (Tg) mice overexpressing MnSOD and EC-SOD were utilized to investigate the potential roles of mitochondrial and extracellular superoxide in 6-OHDA toxicity in vivo. This study demonstrates that intrastriatal 6-OHDA causes both terminal injury and neuronal cell loss in the substantia nigra of mice. Moreover, mice overexpressing mitochondrial MnSOD were significantly protected from nigrostriatal injury to both the substantia nigra neurons and their terminals. Taken together with work in other parkinsonian models, these studies indicate that mitochondrial oxidative stress contributes to a final common pathway of injury in SNc neurons in response to diverse stimuli.
EXPERIMENTAL PROCEDURES
Animals and Treatment. All procedures were conducted in accordance with NIH guidelines for live animal experiments and approved by the University of Pittsburgh Institutional Animal Care and Use Committee. Hemizygous Tg mice overexpressing either MnSOD or EC-SOD, driven by the β-actin promoter, were used along with their respective non-transgenic (non-Tg) wild-type littermate controls. The construction of the MnSOD Tg mice (48) and the EC-SOD Tg mice (1) in the (C57BL/6 X C3H) F1 (B6C3 F1) background have been previously described. MnSOD breeders were the gift of Dr. Ye-Shih Ho, Wayne State University, Detroit, MI, and breeding colonies of both lines are maintained at the University of Pittsburgh. EC-SOD Tg mice were genotyped by PCR amplification of the human EC-SOD transgene as previously described (49) . Mn SOD Tg mice were genotyped using primers to the human MnSOD transgene (Forward:
5'-CCAGTGTTTGCCTTTTATGG-3'; Reverse: 5'-TCGTAGGGCAGGTCGGGGAG-3').
6-OHDA hydrobromide (Sigma, St. Louis, MO) was prepared fresh on the day of use in 0.9% NaCl/0.05% L-ascorbic acid, and stored on ice in the dark. Male mice (10-12 weeks old, 25-30 g) were anesthetized with Nembutal (sodium pentobarbital). 6-OHDA (2.5µg free base) was pump infused into the right striatum and an equivalent volume of vehicle (1 µl) was pump infused into the left striatum through a 30 gauge steel cannula at a rate of 12 µl/hour, using a Kopf stereotaxic instrument set at the following coordinates: AP, +0.8mm; ML, +1.9mm (6-OHDA), -1.9mm (vehicle); DV -3.4mm from bregma. The cannula was withdrawn slowly 3 min after the end of the infusion.
Tissue Preparation and Immunohistochemistry.
Mice were deeply anesthetized using a lethal dose of Nembutal (150 mg/kg i.p.) three weeks after stereotaxic injections, and transcardially perfused with ice cold 0.9% NaCl (pH 7.4), followed by 10% buffered formalin (Fisher). The brains were removed and postfixed for 12-16 hrs in 10% buffered formalin at 4°C, and then transferred to 20% sucrose in 0.1 M PBS at 4°C. For each mouse, serial cryostat-cut coronal sections (30 µm) encompassing the entire striatum were collected sequentially into cryoprotectant solution (0.88 M sucrose, 0.00025 M polyvinyl-pyrolidone (PVP-40), 0.05 M PBS (pH 7.4), 4.8 M ethylene glycol). Free floating sections were processed for tyrosine hydroxylase (TH) immunohistochemistry after removal of cryoprotectant solution. Sections were pre-treated with 1% hydrogen peroxide, washed, and incubated with a rabbit polyclonal antibody (1:500 dilution) specific for TH (Chemicon International, Temecula, CA) containing 0.3% Triton X 100 and 1% normal donkey serum, all in DAKO antibody diluent, S3022, followed by Biotin SP-conjugated affinity purified donkey antirabbit IgG (Jackson ImmunoResearch Laboratories), and developed using the Vector Elite kit (Vector Laboratories) and diaminobenzidine (DAB). After PBS washes, the sections were mounted onto gelatin coated slides and coverslipped with Cytoseal 60.
For deOlmos' amino cupric silver degeneration stains, wild type B6C3 mice were injected with vehicle or 6-OHDA as above, sacrificed at different time points, and perfused with ice cold perfusion wash solution followed by 4% (w/v) paraformaldehyde, 40 g/L sucrose, 14 g/L hydrated sodium cacodylate. The intact brains were sent to NeuroScience Associates (Knoxville, TN) for embedding and amino cupric silver staining with neutral red counterstain (50) . The entire set of brains was embedded into a single unit for processing, sectioning, and staining using MultiBrain Technology, which assures uniformity o f s i l v e r s t a i n i n g a c r o s s c a s e s (http://www.neuroscienceassociates.com/multibrai n.htm).
The entire midbrain was embedded en bloc and serially sectioned. From the series, adjacent 5 µM thick sections were sampled at regular 100 µM intervals through the SNc and mounted onto Superfrost Plus slides (Fisher Scientific). All sections from Tg and littermate controls were immunohistochemically stained for TH in a single run and counterstained with hematoxylin for nuclei. Midbrain slides were heated in an oven (55-60°C) for 30 min, cleared with xylene (3 X 5min), and hydrated through graded ethanol series. Slides were then treated with 1% hydrogen peroxide in 0.1M PBST for 30 min, rinsed with 0.1M PBST and treated with 0.1% pepsin in 0.1N HCl for 10 min. Slides were rinsed with 0.1M PBST and treated with Immunon protein blocking agent (Thermo Shandon, Pittsburgh, PA) for 30 min. Sections were incubated with the same TH rabbit polyclonal antibody and secondary antibodies used for striatal sections, developed with DAB and counterstained with hematoxylin.
Quantitative Image Analysis.
Only animals in which the needle tract demonstrated appropriate injection coordinates were subjected to quantitative analysis of the striatum and the midbrain. Fewer than 2-3 mouse brains/group were excluded due to variation of more than 0.15 mm from the target site in any direction (6% of the average striatal diameter).
All striatal sections were analyzed with a Nikon Eclipse E800 microscope equipped with an Optronics Magna fire 2.0 digital camera, and Metamorph Meta Imaging software, version 4.6. For each striatal section, the right and left striata were defined as regions of interest by tracing. For both 6-OHDA and vehicle injected sides, the autothreshold function was used to define lesion size in pixels, based upon absence of THimmunoreactivity. The lesion area from 5 regularly spaced (150 µm interval) striatal levels centered at the injection site was summated, and expressed as a percentage of the summated pixel area for the entire striatum. There were no significant differences between Tg animals and their littermate controls in the total striatal volume or in the lesion produced by vehicle injection alone.
Counting of SNc neurons.
Cell counts were performed of SNc TH immunoreactive (TH+) neurons and of total SNc neuronal nuclei, defined by size, open chromatin, and nucleoli. Cells with clearly defined nuclei and TH+ soma in the same focal plane were counted in uniformly spaced mesencephalic levels encompassing the SNc beginning at -3.0 mm from bregma +/-30 µm and running rostral to caudal to -3.75 from bregma (51) . Distinction of SNc from the ventral tegmental area was accomplished by restricting analysis to the TH positive cell group lateral to the medial lemniscus or lateral to the line extending dorsally from the cerebral peduncle. The number of neurons on the lesioned side was expressed as percentage of the control vehicleinjected side for each animal.
Stereological counts were performed using a Zeiss Axioplan2 photomicroscope equipped with a Zeiss planapochromat 100X oil objective and a Dell computer using the Neurolucida stereology analysis software (MicroBrightField, Inc., Williston, VT). Based on the optical fractionator method used, cell counting did not depend upon the determination of a volume of reference and a density, but rather relied on random, systematic sampling from a known fraction of a structure's total volume, and neuron number was estimated by extrapolating from this known fraction (52,53). The mathematical formula for estimating total cell number and the algorithm for cell count used in this study are presented in detail in West et al. (52). Cell counts were performed by counting the number of neurons on the right and left SNc of every fourth section throughout the entire extent of the SNc using a standard mouse atlas (51) as anatomical reference. For each animal, the first SNc section to be counted was determined by generating a random number between 1 and 4. To avoid double counting of neurons with unusual shapes, neurons were counted only when their nuclei/nucleoli were optimally visualized using dissector principles (54) . Grid size: 125 µm x 100 µm; counting frame size: 50 µm x 50 µm; NA of lens: 1.4; guard zones: 2 µm; counting fraction: 20%. The coefficient of error of the estimate was less than or equal to 0.05.
We have found that paraffin-embedded midbrain sections offer superior morphologic detail for TH-immunohistochemistry. Thus, we compared counts of 5 µm paraffin sections with those of more commonly used 30 µm cryostat sections, using a separate set of uninjected mice (n=6/genotype). There were no significant differences. For example, EC-SOD Tg mice had 8206 +/-145 TH+ SNc neurons as counted in paraffin sections compared to 8887 +/-523 SNc neurons using cryostat sections (p > 0.2, Student's t-test).
SOD activity assays. CuZnSOD and MnSOD activities were assayed by measuring inhibition of xanthine plus xanthine oxidasemediated cytochrome c reduction at pH 7.8 (55) . All measurements were performed in the presence of 10 µM KCN to inhibit the activity of cellular cytochrome c oxidase. Both CuZnSOD and MnSOD are insensitive to this concentration of KCN. To distinguish the contribution of CuZnSOD and MnSOD to the total SOD activity, the same measurement was also repeated in the presence of 1 mM KCN, which inhibits CuZnSOD, but not MnSOD activity. One unit of SOD activity is defined as the enzyme activity needed to inhibit 50% cytochrome c reduction.
Brain tissue from five mice per group was processed for EC-SOD activity as previously described (56) (57) (58) . Briefly, brain tissue was homogenized in 50 mM potassium phosphate, 0.3M potassium bromide, pH 7.4. After separation from CuZnSOD and MnSOD by concanavalin Asepharose chromatography (59), EC-SOD activity was measured by inhibition of partially acetylated cytochrome c reduction at pH 10.0 as previously described (55) . The total protein concentration in the homogenates was determined using Coomassie Plus protein assay (Pierce, Rockford, IL).
RT-PCR.
The striata and ventral midbrains were dissected from the brains of EC-SOD Tg and nonTg littermates, and RNA isolated by acid phenol-chloroform extractions for RT-PCR analysis of EC-SOD transgene expression as previously described (60) .
Western blots.
In order to analyze regional MnSOD expression in the MnSOD Tg mice, PBSperfused brains from 14-15 mice per group were dissected fresh on ice. Dissected tissues from sets of 3-4 mice were combined by brain region for homogenization and subjected to immunoblot analysis using a rabbit anti-recombinant human MnSOD antibody (61), followed by gel band densitometry as previously described (62, 63) .
Statistical analysis.
Values are expressed as mean +/-SEM except where indicated. For comparisons of two groups, two-tailed Student's t-test was used, with p < 0.05 considered significant. ANOVA followed by Student's t-test with Bonferroni correction was used for multiple comparisons.
RESULTS

Characterization of transgene expression in mouse
brains. Hemizygous MnSOD Tg mice displayed 2.3-fold increased MnSOD activity in total brain homogenates compared with non-Tg littermates. Overexpression of MnSOD did not affect levels of CuZnSOD activity in the brain (Table I) . Previous analysis of these mice using immunogold electron microscopy have confirmed that the Tg mice overexpress MnSOD in mitochondria (64, 65) . Western blot analysis using anti-human MnSOD antiserum, which reacts with both mouse and human MnSOD proteins, was performed to assess MnSOD protein expression in the nigrostriatal system (Fig. 1) . Based upon band densitometry, wild type mice showed roughly equivalent levels of endogenous MnSOD expression in the cortex and striatum, with slightly lower levels observed in the midbrain. The MnSOD Tg mice showed 2.6-fold increased MnSOD protein expression in the midbrain and 4.6-fold increased expression in the striatum. As the striatum and the midbrain constitute the primary sites of injury following intrastriatal 6-OHDA administration, these mice are well suited for testing the hypothesis that mitochondrially derived superoxide contributes to 6-OHDA injury in vivo.
For the EC-SOD Tg mouse line, characterization of brain EC-SOD expression has been previously published (1, 60) . These mice show 4.8-fold increased total brain EC-SOD activity, with significant effects upon both physiologic (hippocampal learning) and pathologic processes (cold-induced brain edema, CNS oxygen toxicity) (1, 5, 60, 66) . RT-PCR was performed to verify transgene expression in the nigrostriatal system (Fig. 2) . In addition, we repeated total brain activity assays in our own breeding colony, finding 3.6 U/mg protein for EC-SOD activity in the heterozygote Tg mice compared to 0.8 U/mg protein in the non-Tg littermate controls.
Characterization of 6-OHDA injury in wild type mice. Initial experiments were conducted using a range of 6-OHDA doses to establish the lesion model. Loss of immunoreactivity for tyrosine hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis, was used to identify injury to SNc neurons and their striatal terminals. TH immunoreactivity correlates tightly with other measures of dopaminergic neuron injury (18, 20) . Intrastriatal injection of 6-OHDA into the right mouse striatum produced a dose-dependent decrease in TH staining, indicating damage to dopaminergic terminals (Fig. 3) . Doses of 5 µg 6-OHDA free base created lesions that extended to or beyond the confines of the striatum at the level of the injection site (not shown). A dose of 2.5 µg 6-OHDA free base yielded consistent subtotal striatal lesions and was selected for neuroprotection experiments. For subsequent quantitative analysis, the auto-thresholding function of MetaMorph image analysis software was used to define the pixel area of the lesion in each of five rostralcaudal striatal planes for each mouse. Normal crossing white matter tracks did not interfere with this analysis (Fig. 3AB) . The vehicle injected left side displayed only minimal disruption of TH immunoreactivity associated with the needle track (Fig. 4, left side, arrows) .
Intrastriatal 6-OHDA injection elicited acute TH terminal and axonal injury in mouse striata as assessed with amino cupric silver degeneration stains (Fig. 3C-E) . This stain selectively impregnates disintegrating terminals and axons, but staining of normal axons is suppressed, allowing identification of irreversible axonal degeneration (50, 67) . At one day after injection, there was widespread, strong, punctate staining of degenerating terminals on the 6-OHDA injected side, while the vehicle injected side exhibited silver staining only along the needle track (Fig. 3C) . Note the intense punctate staining of the 6-OHDA injected side distant from the needle track, with sparing of the unaffected crossing white matter bundles (Fig. 3D) . By 4 days, degenerating axons were readily identified (Fig. 3E ), while only a light background stippling remained on the vehicle injected side. These findings are in agreement with other acute injury models, in which cupric silver staining of terminals peaks at 1-3 days and staining of axons occurs at 3-7 days, with staining disappearing as degenerated debris is cleared (67).
In contrast, there was no visible sign of SNc neuron injury by silver degeneration stain at 3 h to 4 days after lesioning, despite use of the saturating 5 µg dose. This is concordant with published reports in mice and rats, which show that SNc injury is not detectable until 7-10 days after lesion (22) , with the bulk of SNc cell loss occurring in the second week (19, 21, 22) . In rats, SNc lesions remain stable for months after injury (18, 20) . Striatal lesions assessed by TH stains are complete within 1 week, with no significant changes in lesion size at 3 weeks. Based upon these considerations, a 3 week time point was selected for neuroprotection studies.
Effects of MnSOD overexpression on 6-OHDA injury. Groups of 9 MnSOD Tg mice and their non-Tg littermates were injected with 2.5 µg of 6-OHDA free base. The MnSOD Tg mice showed significantly reduced lesion sizes compared to their control littermates (Fig. 4, right side) . There were no differences in striatal size between the right (lesioned) and left (control) sides or between Tg and non-Tg mice (Summated pixel area from 5 uniformly spaced sections: non-Tg left 320837 +/-6243; non-Tg right 321208 +/-5973; Tg left 308386 +/-15350; Tg right 301388 +/-12864). Tg and control mice also showed identical responses to non-specific mechanical trauma associated with vehicle-injection (Fig. 4, left side) . MnSOD overexpression has no effect on the activities of glutathione peroxidase, glutathione reductase, catalase, and glucose-6-phosphate dehydrogenase in this line of Tg mice (48) . There were also no differences in the brain CuZnSOD activity of MnSOD Tg and littermate controls (Table I) . Therefore, protection against 6-OHDA injury to TH terminals in the striatum could be attributed specifically to increased MnSOD activity.
Unilateral 6-OHDA injection resulted in decreased staining of SNc neuron cell bodies and their dendritic processes (Fig. 5) . Image analysis of remaining neurons demonstrated that there was a nonsignificant trend to decreased cell size on the 6-OHDA injected side compared to vehicle injected side at 3 weeks post-lesion (Table II) . MnSOD overexpression conferred significant protection against 6-OHDA-elicited loss of TH+ neurons in the SNc (Fig. 5, A-E ). There were no significant differences in TH+ SNc neuron numbers on the vehicle injected control side between Tg and control littermates (Non-Tg: 6940 +/-374; Tg: 6206 +/-462). Likewise, there were no significant differences in the size of TH+ neuronal soma or nuclei between Tg and nTg littermates on either the vehicle or the 6-OHDA injected sides (Table  II) .
To demonstrate whether loss of TH+ neurons reflected true SNc neuron loss, which has not been previously shown in mice, we also performed counts of neuronal nuclei irrespective of TH status. Loss of SNc neurons was observed in both Tg and non-Tg mice, indicating neuronal cell death rather than potentially reversible effects on TH expression. Moreover, MnSOD Tg mice were significantly protected from 6-OHDA-elicited SNc neuronal cell death (Fig. 6) . . Tg mice showed no significant differences in responses to non-specific mechanical trauma associated with vehicle-injection (Fig. 7, left side) . There were no significant differences in SNc neuron numbers on the vehicle injected control side between Tg and non-Tg littermates (Non-Tg: 9291 +/-501; Tg: 8206 +/-145).
Effects of EC-SOD
Discussion.
Mice overexpressing mitochondrial MnSOD are protected from 6-OHDA injury to the TH+ striatal terminals and cell bodies of SNc neurons (25% reduction in striatal lesion size and 60% reduction in SNc neuron cell loss). In contrast, Tg mice overexpressing EC-SOD showed no protective effects. These findings support a role for mitochondrially-derived superoxide in SNc neuron cell death elicited by 6-OHDA.
Mitochondrial dysfunction has long been implicated in PD based upon post-mortem tissue studies (68) and studies of cybrid cells containing mitochondria derived from patients with PD (69, 70) . While measured alterations in PD patient material may occur as a result of cellular dysfunction or as primary/amplifying mechanisms that cause neurodegeneration, a role for mitochondrial ROS in striatal terminal injury has been supported by observations that MnSOD overexpression protects against loss of striatal dopamine levels after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (3) and methamphetamine (65) . However, the ability of MnSOD to protect against SNc neuronal loss has not been previously demonstrated. The results presented here indicate that MnSOD overexpression can protect against both terminal injury and SNc neuronal cell death.
MPTP is metabolized in the brain to MPP+, an inhibitor of mitochondrial complex I activity. Complex I inhibition enhances superoxide generation (71) . In addition, mitochondria can become uncoupled during hypoxic-ischemic insults, resulting in enhanced oxidative injury upon reperfusion (72) . Likewise, impairment of oxidative phosphorylation has been associated with seizures and excitotoxicity. Mitochondrial ROS may also play a role in regulating survival and death-associated signaling pathways (73) , and altered mitochondrial expression of signaling proteins has been observed in degenerating neurons (74) . As mitochondrial dysfunction is intricately linked to complex I inhibition, ischemic injury and excitotoxicity, it is perhaps not surprising to find that MnSOD overexpression confers protection in these types of models (3, (75) (76) (77) .
There are several studies in the literature suggesting that mechanisms of action between MPP+ and 6-OHDA are different (39, (78) (79) (80) . Mitochondria are directly targeted by MPP+ (3). In contrast, a primary role of mitochondrial dysfunction in the 6-OHDA model has been controversial, based upon in vitro systems (38) (39) (40) (41) . Although extracellular and non-mitochondrial mechanisms have been proposed for 6-OHDA toxicity to cultured cells (36, 39, 40, 42, 43) , the results of the current study indicate that oxidative mitochondrial mechanisms contribute to 6-OHDAelicited injury in vivo.
Although there have been numerous studies indicating profound effects of a 5-fold change in EC-SOD activity upon brain pathophysiology in this line of transgenic mice (1, 5, 47, 49, 60, 66) , it is possible that the dose of 6-OHDA given exceeds the capacity of the overexpressed EC-SOD, which accounts for only a minor percentage of total SOD activity in the brain. However, the lack of protection by EC-SOD does correlate mechanistically with studies that suggest internalization is important for 6-OHDA toxicity in vivo (14) . In addition, even in cell culture systems in which 6-OHDA toxicity likely is initiated extracellularly, extracellular administration of CuZnSOD does not confer protection (32, 63) . In contrast, metalloporphyrin antioxidant mimetics, which penetrate into mitochondrial fractions after extracellular administration (81), protect against 6-OHDAelicited neuronal cell death (32). The ability of mitochondrially targeted antioxidants to protect in both in vivo and in vitro systems suggests a secondary mitochondrial source of ROS that contributes to 6-OHDA-initated cell death.
While oxidative stress is a leading pathogenic hypothesis for dopaminergic neuron degeneration, different models may elicit oxidative stress through different mechanisms. In the MPTP model, ROS can emanate from the cytosol and mitochondria of dopaminergic neurons (3, (82) (83) (84) . Deficits in complex I activity, such as that induced by the pesticide rotenone, also increases intracellular oxidative stress (85) . Patients with sporadic Parkinson's disease show deficits in complex I activity that can be transmitted through mitochondrial DNA (69, 70) , and mitochondrial oxidative stress may be a central mechanism associated with the parkinsonian DJ-1 mutation (86) . Overexpression of alpha-synuclein, the first protein found to be mutated in parkinsonian families (87) , may also promote mitochondrial injury and oxidative stress (88, 89) . Thus, mitochondrial oxidative stress serves as a potential integration point for many divergent forms of injury relevant to Parkinsonian neurodegeneration.
ROS associated with 6-OHDA has been assumed to derive from direct autoxidation (35) , with a large extracellular component in most cell culture studies. However, 6-OHDA is relatively short-lived, whereas SNc degeneration proceeds over a sustained period of time after a single injection (19) . Just as recent data indicate a second wave of extracellular microglial derived superoxide in MPTP injury (90) , the ability of MnSOD to protect the nigrostriatal system in this study suggests that more than one source of ROS may operate in 6-OHDA toxicity. It is interesting to note that 6-OHDA lesioning causes decreased MnSOD message expression in the SNc (91) . It has also been suggested that neuronal populations that fail to induce MnSOD show increased susceptibility in the neurodegenerative disease amyotrophic lateral sclerosis (92) . Effective therapies for neurodegenerative diseases may need to provide antioxidant activity to more than one compartment, as well as potentially including compounds to regenerate the antioxidants (25) . (B) Following digital image capture, the striata were defined as regions of interest (dark gray) and the size of the lesion (white) determined using the auto-thresholding function of MetaMorph software. For each mouse, this was performed for the vehicle injected and the 6-OHDA injected sides on five uniformly spaced levels spanning the rostral-caudal extent of the striatum. Scale bar: 1000 µm. (C) Amino cupric silver degeneration stain of a representative mouse reveals intense staining of the 6-OHDA lesioned right striatum at 1 day after injection. In contrast, cupric silver staining was limited to the region of the needle track on the vehicle-injected left side. (D) Intense punctate staining of striatal terminals in a region distant to the needle track at 1 day after 6-OHDA injection. Note sparing of the crossing white matter bundles that do not contain dopaminergic processes (asterisks). (E) Axonal degeneration is evident at 4 days after 6-OHDA injection (arrows). Scale bar: 40 µm 
